Sustained Remission of More Than 5 Years After Thalidomide-Cyclophosphamide-Prednisone Discontinuation in Idiopathic Multicentric Castleman Disease: A Single-Centre Retrospective Study

Dang, Yue; Gao, Yuhan; Li, Siyuan; Zhang, Lu; Li, Jian

Sustained Remission of More Than 5 Years After Thalidomide-Cyclophosphamide-Prednisone Discontinuation in Idiopathic Multicentric Castleman Disease: A Single-Centre Retrospective Study [Turk J Hematol]

Turk J Hematol. Ahead of Print: TJH-99390 | DOI: 10.4274/tjh.galenos.2026.99390

Sustained Remission of More Than 5 Years After Thalidomide-Cyclophosphamide-Prednisone Discontinuation in Idiopathic Multicentric Castleman Disease: A Single-Centre Retrospective Study

Yue Dang, Yuhan Gao, Siyuan Li, Lu Zhang, Jian Li
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Keywords: idiopathic multicentric Castleman disease, TCP, discontinuation

Corresponding Author: Lu Zhang, China
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar